Luhan Pharmachem Co., Ltd.

Home > Products > Intermediates & Extracts > Oncology >

Dactinomycin

\

Dactinomycin is one of the older chemotherapy drugs, having gained approval from the Food and Drug Administration (FDA) in 1982. This highly potent and effective cytotoxic agent is a mixture of substances produced by the bacteria Streptomyces parvullus. Its toxic properties prevent its use as an antibiotic. cas no. :50-76-0

About Us

Company Profile

Advantages

Strong R & D center

Qualifications

Products

APIs

Intermediates & Extracts

In development

Services

API Sourcing and Regulatory Support

Custom Synthesis

Logistics and Customs Clearance

Contact Us

Tel: +86 0871 6511 0906 (GMT+8 AM9:00-AM:12:00 PM1:30-PM6:00)

cell phone:188 1221 6310

Fax:0871-63602606

Email: info@luhancn.com

Address:Room 3301,33rd Floor Building B, Vogue Garden Plaza, No.1004 Beijing Road, Kunming, Yunnan Province, P. R. China 650000